神経調節装置の世界市場：製品、用途、エンドユーザー別-2025-2030年予測

神経調節装置市場は、2023年に86億6,000万米ドルと評価され、2024年には97億9,000万米ドルに達すると予測され、CAGR 13.54％で成長し、2030年には210億7,000万米ドルに達すると予測されています。

神経調節装置は、特定の神経学的標的に電気的または薬学的薬剤を直接送達することによって神経活動を調節するために採用される高度な技術装置です。これらの機器の応用範囲は多岐にわたり、慢性疼痛、てんかん、パーキンソン病、うつ病などの症状に対応します。これらは、従来の治療法では不十分なアンメット・メディカル・ニーズを満たすために不可欠なものです。これらの機器の必要性は、最小限の侵襲で的を絞った解決策を提供し、患者のQOLを向上させ、手術や長期投薬に代わる選択肢を提供する能力から生じる。主なエンドユーザーには病院、診療所、専門研究センターが含まれ、ヘルスケア環境における幅広い適用性が強調されています。市場開拓は、神経疾患の有病率の増加、機器の有効性と安全性を高める技術の進歩、先進国や新興経済諸国におけるヘルスケア投資と相まって高まる意識といった要因に大きく影響されます。個別化された神経調節治療のための人工知能の活用や、メンタルヘルス治療への応用拡大がチャンスです。推奨事項としては、ユーザーの利便性を向上させるために機器の携帯性とバッテリー持続時間を強化すること、普及率を加速させるためにヘルスケアプロバイダーとの戦略的パートナーシップを拡大することが挙げられます。しかし、高額な機器コスト、厳しい規制要件、機器に関連する潜在的な合併症などの課題が、市場拡大の妨げとなる可能性があります。また、ヘルスケア専門家の技術的スキルの限界も、機器の利用に影響を及ぼす可能性があります。したがって、トレーニングプログラムの育成と機器インターフェースの簡素化が重要です。技術革新の中心は、低侵襲技術の改良、ワイヤレス神経調節の探求、転帰改善のためのリアルタイムデータ解析の統合です。この市場は、絶え間ない技術進歩と患者中心の治療ソリューション重視の高まりによってダイナミックに動いています。ハイテク企業とヘルスケア機関のコラボレーションは、進化する情勢をナビゲートし、神経調節療法の未来を形作る画期的な技術の研究を可能にする上で極めて重要です。

市場力学：急速に進化する神経調節装置市場の主要市場インサイトを公開

神経調節装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 神経疾患および神経損傷の有病率の上昇
  • 神経調節および神経刺激技術への注目の高まり
  • 神経調節の応用拡大
• 市場抑制要因
  • 神経調節手技のコスト高
• 市場機会
  • 神経疾患の研究に対する政府の支援
  • 新しい神経調節装置の開発
• 市場の課題
  • 厳しい規制の枠組みと時間のかかる承認プロセス
  • 世界中の専門技術者の不足

ポーターの5つの力：神経調節装置市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：神経調節装置市場における外部からの影響の把握

外部マクロ環境要因は、神経調節装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析神経調節装置市場における競合情勢の把握

神経調節装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス神経調節装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、神経調節装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨神経調節装置市場における成功への道筋を描く

神経調節装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 神経疾患および神経損傷の罹患率の上昇
    • 神経調節および神経刺激技術への注目の高まり
    • 神経調節の応用の拡大
  • 抑制要因
    • 神経調節処置の高額な費用
  • 機会
    • 神経疾患の調査に対する政府の支援
    • 小説の開発神経調節装置
  • 課題
    • 厳格な規制枠組みと時間のかかる承認プロセス
    • 世界中で技術専門知識が不足している
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 神経調節装置市場：製品別

• 脳深部刺激装置
• 仙骨神経刺激装置
• 脊髄刺激装置
• 経頭蓋磁気刺激装置
• 迷走神経刺激装置

第7章 神経調節装置市場：用途別

• 神経疾患
• 疼痛管理
• 呼吸器疾患

第8章 神経調節装置市場：エンドユーザー別

• 病院
• 専門クリニックと外来センター

第9章 南北アメリカの神経調節装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の神経調節装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの神経調節装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Aleva Neurotherapeutics SA
• Avanos Medical, Inc.
• Axonics, Inc.
• B. Braun SE
• Beijing PINS Medical Co., Ltd.
• Bioventus
• Boston Scientific Corporation
• LivaNova PLC
• Medtronic PLC
• Nevro Corp.
• Second Sight Medical Products Inc.
• SPR Therapeutics, Inc.
• Stimwave LLC
• SunMed

LIST OF FIGURES

• FIGURE 1. NEUROMODULATION DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. NEUROMODULATION DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEUROMODULATION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEUROMODULATION DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS & AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Neuromodulation Devices Market was valued at USD 8.66 billion in 2023, expected to reach USD 9.79 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 21.07 billion by 2030.

Neuromodulation devices are advanced technological equipment employed to modulate nerve activity by delivering electrical or pharmaceutical agents directly to specific neurological targets. The scope of these devices spans a variety of applications, addressing conditions such as chronic pain, epilepsy, Parkinson's disease, and depression. They are vital in bridging unmet medical needs where traditional therapies fall short. The necessity for these devices arises from their ability to provide targeted solutions with minimal invasiveness, improving patients' quality of life and offering alternatives to surgery or long-term medication use. Key end-users include hospitals, clinics, and specialized research centers, emphasizing their broad applicability in healthcare settings. Market growth is significantly influenced by factors such as increasing prevalence of neurological disorders, technological advancements enhancing device efficacy and safety, and rising awareness coupled with healthcare investments in developed and emerging economies. Opportunities lie in leveraging artificial intelligence for personalized neuromodulation therapies and expanding applications in mental health treatment. Recommendations include enhancing device portability and battery life to improve user convenience and expanding strategic partnerships with healthcare providers to accelerate adoption rates. However, challenges such as high device costs, stringent regulatory requirements, and potential device-related complications can hinder market expansion. Limitations in technical skillsets among healthcare professionals may also affect device utilization. Hence, fostering training programs and simplifying device interfaces are critical. Innovation should center on refining minimally invasive techniques, exploring wireless neuromodulation, and integrating real-time data analytics for improved outcomes. This market is dynamic, driven by continuous technological progress and a growing emphasis on patient-centered therapeutic solutions. Collaborations between tech companies and healthcare institutions are crucial to navigate the evolving landscape, enabling research into breakthrough technologies that can shape the future of neuromodulatory therapies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neuromodulation Devices Market

The Neuromodulation Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of neurological disorders and nerve injuries
  • Growing focus on neuromodulation & neurostimulation technologies
  • Expanding applications of neuromodulation
• Market Restraints
  • High cost of neuromodulation procedures
• Market Opportunities
  • Government support for research on neurological disorders
  • Development of novel neuromodulation devices
• Market Challenges
  • Stringent regulatory frameworks and time-consuming approval processes
  • Lack of technical expertise across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Neuromodulation Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neuromodulation Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neuromodulation Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neuromodulation Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neuromodulation Devices Market

A detailed market share analysis in the Neuromodulation Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neuromodulation Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neuromodulation Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neuromodulation Devices Market

A strategic analysis of the Neuromodulation Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neuromodulation Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Avanos Medical, Inc., Axonics, Inc., B. Braun SE, Beijing PINS Medical Co., Ltd., Bioventus, Boston Scientific Corporation, LivaNova PLC, Medtronic PLC, Nevro Corp., Second Sight Medical Products Inc., SPR Therapeutics, Inc., Stimwave LLC, and SunMed.

Market Segmentation & Coverage

This research report categorizes the Neuromodulation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Transcranial Magnetic Stimulators, and Vagus Nerve Stimulators.
• Based on Application, market is studied across Neurological Disorders, Pain Management, and Respiratory Disorders.
• Based on End User, market is studied across Hospitals and Specialty Clinics & Ambulatory Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of neurological disorders and nerve injuries
    • 5.1.1.2. Growing focus on neuromodulation & neurostimulation technologies
    • 5.1.1.3. Expanding applications of neuromodulation
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of neuromodulation procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Government support for research on neurological disorders
    • 5.1.3.2. Development of novel neuromodulation devices
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory frameworks and time-consuming approval processes
    • 5.1.4.2. Lack of technical expertise across the globe
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neuromodulation Devices Market, by Product

• 6.1. Introduction
• 6.2. Deep Brain Stimulators
• 6.3. Sacral Nerve Stimulators
• 6.4. Spinal Cord Stimulators
• 6.5. Transcranial Magnetic Stimulators
• 6.6. Vagus Nerve Stimulators

7. Neuromodulation Devices Market, by Application

• 7.1. Introduction
• 7.2. Neurological Disorders
• 7.3. Pain Management
• 7.4. Respiratory Disorders

8. Neuromodulation Devices Market, by End User

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Specialty Clinics & Ambulatory Centers

9. Americas Neuromodulation Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Neuromodulation Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Neuromodulation Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Aleva Neurotherapeutics SA
• 3. Avanos Medical, Inc.
• 4. Axonics, Inc.
• 5. B. Braun SE
• 6. Beijing PINS Medical Co., Ltd.
• 7. Bioventus
• 8. Boston Scientific Corporation
• 9. LivaNova PLC
• 10. Medtronic PLC
• 11. Nevro Corp.
• 12. Second Sight Medical Products Inc.
• 13. SPR Therapeutics, Inc.
• 14. Stimwave LLC
• 15. SunMed